Get started
sequentialvzion

TASE:BONS

Long
BONUS BIOGROUP (TASE:BONS)  
sequentialvzion Updated   
TASE:BONS   BONUS BIOGROUP
Trend Analysis Chart Patterns Technical Indicators TASE bons sequential sequentialvzion sequentialvision sequentialvsion vir2alexport
1
0
trendanalysis chartpattern indicator tase bons sequential sequentialvzion sequentialvision sequentialvsion vir2alexport
Oramed Pharm - is a clinical stage biopharmaceutical company.

2022/3 Planned launch of MesenCure multinational phase III clinical trial; and phase II/III clinical trial in the US evaluating the safety and efficacy of BonoFillTM injectable live bone graft for bone regeneration.
Comment:
It's Bonus Biogroup, of course! Wrong company name in description was mistakenly copy-pasted (!)

Related Ideas

sequentialvzion
TASE:KMDA
sequentialvzion
TASE:ORMP
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.